Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Mettler-Toledo International's enterprise value is €25,480 Mil.
Mettler-Toledo International's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €1,077 Mil. Therefore, Mettler-Toledo International's EV-to-EBITDA for today is 23.66.
The historical rank and industry rank for Mettler-Toledo International's EV-to-EBITDA or its related term are showing as below:
FRA:MTO'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 18.46 Med: 24.82 Max: 37.78
Current: 23.11
During the past 13 years, the highest EV-to-EBITDA of Mettler-Toledo International was 37.78. The lowest was 18.46. And the median was 24.82.
FRA:MTO's EV-to-EBITDA is ranked worse than 69.23% of 117
companies
in the Medical Diagnostics & Research industry
Industry Median: 14.4
vs FRA:MTO: 23.11
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Mettler-Toledo International (FRA:MTO) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Mettler-Toledo International's PE Ratio (TTM) for today is calculated as:
Mettler-Toledo International's share price for today is €1166.00.
Mettler-Toledo International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €36.612.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Mettler-Toledo International's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mettler-Toledo International EV-to-EBITDA vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Mettler-Toledo International's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Mettler-Toledo International's EV-to-EBITDA falls into.
Mettler-Toledo International's current Enterprise Value is €25,480 Mil.
Mettler-Toledo International's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,077 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mettler-Toledo International (FRA:MTO) has a EV-to-EBITDA of 23.66 as of Jul. 26, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Mettler-Toledo International. This is near median its historical median of 24.82. Over the past decade, Mettler-Toledo International's EV-to-EBITDA has ranged from 18.46 to 37.78. According to the industry distribution chart, Mettler-Toledo International ranks #81 out of 117 companies in the Medical Diagnostics & Research industry, placing it in the top 69.2%.
Is Mettler-Toledo International's EV-to-EBITDA too high?
Mettler-Toledo International's current EV-to-EBITDA of 23.66 is near median its 10-year median of 24.82. Over the past 10 years, this metric has ranged from a low of 18.46 to a high of 37.78. The Medical Diagnostics & Research industry median EV-to-EBITDA is 14.40. Mettler-Toledo International's value of 23.66 is 64.3% above this industry median. Based on the distribution chart, Mettler-Toledo International ranks #81 out of 117 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Mettler-Toledo International has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Mettler-Toledo International's EV-to-EBITDA compare to DGX and LH?
According to the Medical Diagnostics & Research industry distribution chart, Mettler-Toledo International ranks #81 out of 117 companies for EV-to-EBITDA. This places Mettler-Toledo International in the lower half of its industry. The industry median EV-to-EBITDA is 14.40. Mettler-Toledo International's value of 23.66 is 64.3% above this benchmark. Historically, Mettler-Toledo International's own EV-to-EBITDA has ranged from 18.46 to 37.78 over the past decade. While the company's 10-year median is 24.82 vs. the industry median of 14.40, Mettler-Toledo International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Diagnostics & Research company?
The median EV-to-EBITDA among Medical Diagnostics & Research companies is 14.40, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mettler-Toledo International's current EV-to-EBITDA of 23.66 is 64.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Mettler-Toledo International. For the Medical Diagnostics & Research industry, the median EV-to-EBITDA is 14.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mettler-Toledo International's current EV-to-EBITDA is 23.66, which is near median its own 10-year median of 24.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mettler-Toledo International stock overvalued right now?
Mettler-Toledo International (FRA:MTO) has a current EV-to-EBITDA of 23.66. The stock's GF Value™ is €1,263.21, compared to a current price of €1,166.00 — trading 7.7% below its estimated fair value. The current EV-to-EBITDA is 23.66, which is near median its 10-year median of 24.82 and 64.3% above the Medical Diagnostics & Research industry median of 14.40. Mettler-Toledo International's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Mettler-Toledo International (FRA:MTO), the current EV-to-EBITDA is 23.66 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mettler-Toledo International (FRA:MTO) Overvalued in 2026?
Based on GuruFocus' analysis, Mettler-Toledo International stock appears to be undervalued.
The current stock price of €1,166.00 is trading 7.7% below its estimated GF Value™ of €1,263.21.
Key valuation signals for FRA:MTO:
EV-to-EBITDA: 23.66 (near median its 10-year median of 24.82)
GF Value™: €1,263.21 vs. price of €1,166.00 (7.7% below fair value)
Industry Position: 64.3% above the Medical Diagnostics & Research median (#81 of 117)
No single metric tells the full story. See the FRA:MTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.
92GF Score
Get the complete analysis for FRA:MTO
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MTO has been successfully added to your 
